Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-8521 in Type 2 Diabetes Mellitus
NCT02492763Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jul 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of mk-8521 in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Jul 2015; status: terminated.
02
Drugs
mk-8521
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02492763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492763.